1 suspended. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Suspended 1 |
Follow Prostatic Neoplasm: new trials by email Literature Review of Prostatic Neoplasm trials Research Report on Prostatic Neoplasm
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 1a/1b Study to Evaluate the Safety of EZN-4176, in Adult Patients With Castration-Resistant Prostate Cancer EZN-4176 - Prostatic Neoplasm | Phase 1 | Suspended | Enzon Pharmaceuticals, Inc. | 150 | 2011-03-01 | 2012-12-18 |
Adenocarcinoma (1) · Bulbo-Spinal Atrophy, X-Linked (1) · Neoplasm Metastasis (1) · Prostatic Neoplasms (1)
Carcinoma (1) · Central Nervous System Diseases (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Genetic Diseases, Inborn (1) · Genetic Diseases, X-Linked (1) · Genital Diseases (1) · Genital Diseases, Male (1) · Genital Neoplasms, Male (1) · Heredodegenerative Disorders, Nervous System (1) · Male Urogenital Diseases (1) · Motor Neuron Disease (1) · Muscular Atrophy, Spinal (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms by Site (1)
Enzon Pharmaceuticals, Inc. (1)
United Kingdom (1) · United States (1)
Aby Buchbinder, MD (1) · Daniel Danila, MD (1) · Johann de Bono, MD (1)